slides · global inventory
Turn
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 37,461
Current window 26,011-26,040
Pages 1,249
Rows per page 30
Beat
26,011-26,040 of 37,461
07
The slide uses a standard drug pipeline asset summary format.AbCellera | Investor Presentation Deck | 22 slides · AbCellera
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
08
AbCellera | Investor Presentation Deck | 22 slidesAbCellera | Investor Presentation Deck | 22 slides · AbCellera
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
09
The slide uses a split-layout with a narrative on the left and a list of strategic pillars on the right.AbCellera | Investor Presentation Deck | 22 slides · AbCellera
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
10
The slide uses a three-column layout to define strategic focus areas.AbCellera | Investor Presentation Deck | 22 slides · AbCellera
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
11
AbCellera | Investor Presentation Deck | 22 slidesAbCellera | Investor Presentation Deck | 22 slides · AbCellera
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
12
AbCellera | Investor Presentation Deck | 22 slidesAbCellera | Investor Presentation Deck | 22 slides · AbCellera
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
09
The slide uses a standard financial reporting format for public companies.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · The Breakthrough1 hit
10
The slide uses a patient photo as the primary visual, with a summary bar at the bottom.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · The Breakthrough1 hit
11
The slide uses a grid layout to present four key performance pillars and a sidebar for real-world evidence.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · The Breakthrough1 hit
12
The slide uses a series of arrows to represent growth vectors. Data points are 6,000, 17,000, and 31,000.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · The Breakthrough1 hit
10
Includes a 25th-anniversary branding graphic.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
11
Includes a navigation bar at the top and a footnote regarding rounding and CER adjustments.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
10
Uses a 'case study' framework to validate the proposed strategy by drawing a parallel to an existing successful drug (Osimertinib).Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
06
The slide uses a timeline to connect corporate strategy to specific clinical trial milestones.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Solution1 hit
07
The slide features a split layout with a left-hand column for advisors/board and a right-hand grid for the leadership team, plus a footer highlighting 12 prior FDA approvals.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Solution1 hit
08
The slide uses a Gantt-style visualization to represent drug development stages.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Solution1 hit
09
The slide uses a structured table to contrast two distinct patient populations (ALK+ vs ROS1+) across three lines of therapy (1L, 2L, 3L+).Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
Uses a 'cite_precedent' framework to validate the strategy by comparing it to the established success of Osimertinib.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
07
Includes a biological pathway diagram and a dose-response curve showing target validation.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
The slide presents experimental evidence (Western blot) supporting the mechanism of action for NXP800 in ARID1a-deficient cancer cells.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
Includes two line charts showing tumor volume reduction over time and a table showing patient incidence for target indications.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
Nuvectis Pharma | Investor Presentation Deck | 25 slidesNuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Voice Of Customer1 hit
16
The charts are kinome dendrograms (KinomeScan style).Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Voice Of Customer1 hit
17
The slide uses a structural biology mechanism of action (MOA) comparison to demonstrate competitive advantage.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Voice Of Customer1 hit
13
The slide uses a circular process diagram to represent the platform's core functions.P3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Beat · Solution1 hit
05
Pathward Financial | Results Presentation Deck | 34 slidesPathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
06
The slide uses a consistent color scheme (light blue for Q1 2023, dark blue for Q1 2024) and percentage change callouts for each metric.Pathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
07
The slide highlights that total deposits remained flat (0% change) year-over-year.Pathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
The slide uses a waterfall-style bridge to show growth between two periods.Pathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
The donut chart shows total liquidity of $3.807B. The bar chart shows Q1 2024 share repurchases of 232,588 shares.Pathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit